Follow the KAO share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the authority of ASX. Operating in the Health Care sector, KAO has published 2 reports. Market capitalisation: €37.6m. The latest transaction was disclosed on 24 May 2026 (Purchase). The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
KAO is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on the development and commercialization of innovative pharmaceutical products.